Blueprint Medicines Corp (BPMC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

45 SIDNEY STREET CAMBRIDGE, MA 02139

Blueprint Medicines Corporation develops and distributes biomedical treatments. The Company researches and produces medicines and treatments for cancer targeting the molecular differences. Blueprint Medicines focuses selective drugs for genomically defined cancer patients.

Data based on most recent fiscal year report
Market Cap3.819 Billion Shares Outstanding42.88 Million Avg Volume676.46 Thousand
1-Yr BETA vs S&P TR Current Ratio15.98 Quick Ratio15.98
View SEC Filings from BPMC instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BPMC now:
Filers who had this stock in their top 10: 8 5 (0.52%)
13F Filers holding this stock: 217 38 (3.93%)
Aggregate 13F shares on 06/30/2019: 48.729 Million 8.009 Million
Aggregate 13F shares on 03/31/2019: 47.609 Million 8.156 Million
Percent change: 2.35% -1.80%
Funds creating new positions: 54 10
Funds Adding to an existing position: 91 12
Funds closing out their position: 34 11
Funds reducing their position: 45 12
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BPMC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

30.5 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

30.5 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOLDBERG MARK ALAN

  • Director
0 2019-09-30 1

COATS LONNEL PRESIDENT AND CEO

  • Officer
  • Director
227,539 2019-09-18 2

HURLEY ARIEL PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2019-09-16 8

LYNCH DANIEL

  • Director
391,277 2019-09-12 1

BORAL ANTHONY L. CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-20 3

LYDON NICHOLAS

  • Director
107,727 2019-08-19 4

ALBERS JEFFREY W. CEO AND PRESIDENT

  • Officer
  • Director
28,961 2019-08-19 7

HAVILAND KATE CHIEF OPERATING OFFICER

  • Officer
15,865 2019-08-19 4

ROWLAND CHARLES A JR

  • Director
0 2019-07-31 2

LEVIN MARK J

  • Director
  • 10% Owner
5,962,202 2019-07-22 0

DEMETRI GEORGE

  • Director
0 2019-07-12 3

BORISY ALEXIS

  • Director
60,906 2019-06-27 2

SEELY LYNN

  • Director
0 2019-06-19 1

DORSCH MARION CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-06-17 3

STARR KEVIN P

0 2019-06-05 0

MCCAIN TRACEY L

  • Director
0 2019-05-29 1

LENGAUER CHRISTOPH

  • Director
0 2019-04-17 0

FMR LLC

  • SEE REMARK 1
3,738,248 2019-04-01 0

LANDSITTEL MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-01 1

MURRAY CHRISTOPHER K. SVP, TECHNICAL OPERATIONS

  • Officer
0 2019-03-01 1

ROSSI CHRISTINA CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-03-01 3

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

STARR KEVIN P

  • 10% Owner
No longer subject to file 2017-06-14 0

KUVALANKA KYLE D. CHIEF OPERATING OFFICER

  • Officer
0 2017-02-10 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HURLEY ARIEL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-09-16 M 415 $1.87 a 415 0.00 direct yes

HURLEY ARIEL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-09-16 M 415 d 12,599 0.00 direct yes

HURLEY ARIEL - Officer PRINCIPAL ACCOUNTING OFFICER

2019-09-16 S 415 $78.14 d 0 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-21 S 8,700 $80.01 d 0 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-21 M 8,700 d 13,030 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-21 M 8,700 $8.80 a 8,700 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-20 M 1,300 $8.80 a 1,300 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-20 M 1,300 d 21,730 0.00 direct yes

BORAL ANTHONY L. - Officer CHIEF MEDICAL OFFICER

2019-08-20 S 1,300 $80.44 d 0 0.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 M 20,000 $1.87 a 48,961 28,961.00 direct yes

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2019-08-19 S 95 $85.00 d 15,865 15,865.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 S 12,166 $81.33 d 28,961 28,961.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 S 800 $84.42 d 48,061 28,961.00 direct yes

LYDON NICHOLAS - Director

2019-08-19 G 20,000 d 107,727 107,727.00 direct

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2019-08-19 M 95 $16.28 a 15,960 15,865.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 S 6,634 $82.04 d 41,127 28,961.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 S 100 $85.56 d 48,861 28,961.00 direct yes

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2019-08-19 M 95 d 15,552 15,865.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 M 20,000 d 18,080 28,961.00 direct yes

ALBERS JEFFREY W. - Director - Officer CEO AND PRESIDENT

2019-08-19 S 300 $82.85 d 47,761 28,961.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments